Prostate Cancer - Results from #80

PSA bounce: understanding temporal fluctuations in prostate cancer after external radiotherapy. December 24, 2024

Socio-Economic Determinants of Cancer Screening Adherence Among Cancer Survivors: Analysis from 2020 Behavioral Risk Factor Surveillance System. December 24, 2024

Medication Prescription Policy for US Veterans With Metastatic Castration-Resistant Prostate Cancer: Causal Machine Learning Approach. December 23, 2024

Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader. December 23, 2024

Survival outcomes of apalutamide as a starting treatment: impact in real-world patients with metastatic hormone sensitive prostate cancer (OASIS). December 23, 2024

Use of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Nodal Staging in Prostate Cancer and Tailoring of Treatment: A Continuing Conundrum. December 23, 2024

The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM December 23, 2024

Salvage Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer. December 23, 2024

Performance of PSMA-PET/CT as verified by bone biopsy for diagnosing osseous metastases of prostate cancer. December 23, 2024

Landscape and prognostic significance of oncogene drivers in metastatic castration sensitive prostate cancer. December 20, 2024

Management strategies for radio-recurrent prostate cancer: a comprehensive review. December 20, 2024

Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy? December 20, 2024

Optimal Treatment Strategies for Hormone-sensitive Metastatic Prostate Cancer: Does Local Radiotherapy Play a Role in High-volume Disease? December 20, 2024

HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression. December 20, 2024

PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity. December 20, 2024

Comparative analysis of gut microbiota in hormone-sensitive and castration-resistant prostate cancer in Japanese men. December 20, 2024

A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. December 20, 2024

Personalized Mobile App-Based Program for Preparation and Recovery After Radical Prostatectomy: Initial Evidence for Improved Outcomes From a Prospective Nonrandomized Study. December 20, 2024

Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis. December 19, 2024

Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials. December 19, 2024

Page 5 of 1451